IMAGE ANALYSIS LIMITED - Key Persons
Job Titles:
- Scientific Advisor
- Director of the UCLA Brain Tumor Imaging Laboratory
Dr. Ellingson is the Director of the UCLA Brain Tumor Imaging Laboratory (BTIL), Co-Director of the Center for Computer Vision and Imaging Biomarkers, and a member of the UCLA Brain Tumor Program. Dr. Ellingson's research involves the development, testing, and implementation of advanced MRI and PET imaging biomarkers for the characterization of brain tumor biology and response evaluation in clinical trials. Dr. Ellingson has been a co-author on more than 90 peer-reviewed original research articles relating to neuroimaging. Dr. Ellingson has extensive experience performing data management and imaging analysis in multicenter clinical trials in brain cancer and he currently serves as the Chair of the Neuro-Imaging Committee for the NIH-funded Adult rain Tumor Consortium (ABTC), Chair of the Imaging Committee for the en and Catherine Ivy Foundation Consortium for Early Phase Clinical Trials, Chair of the Imaging Committee for the new Glioblastoma Global Adaptive Trial, is a member of the ACRIN head/neck/neuro committee imaging committee, and is the co-chair of the imaging committee for specific brain tumor trials run by the Alliance for Clinical Trials in Oncology.
Job Titles:
- Chairman
- Chairman Biotech and Pharma Drug Development Strategy
Job Titles:
- Director Bio Innovation and Strategic Partnering
With 20 years of experience within the Healthcare industry, mainly in Medical Imaging, David dedicates his attention to Business Development and advising Life Science companies how to use imaging-based markers to accelerate their drug development. David also has vast experience in plain and cross-sectional radiologic imaging including CMR (Cardiac MRI).
Job Titles:
- Scientific Advisor / Professor of Gastroenterology, IBD Expert
David T. Rubin, MD, is a renowned gastroenterologist who specializes in the treatment and assessment of digestive diseases. His clinical expertise includes inflammatory bowel diseases (Crohn's disease and ulcerative colitis).
Job Titles:
- Associate Professor, Head of Scleroderma Programme at the Leeds Institute of Rheumatic
- Scientific Advisor / Expert in Scleroderma Clinical Research
Dr. Francesco Del Galdo is an Associate Professor, Head of Scleroderma Programme at the Leeds Institute of Rheumatic and Musculoskeletal Medicine. His PhD studies and post doctoral fellowship focused on early events in the pathogenesis of Scleroderma. He spent 5 years in the Scleroderma Center of Thomas Jefferson University in Philadelphia, USA. and pioneered application of Optical Coherence Tomography, MRI and serum biomarkers of overall fibrosis as outcome measures of activity and early diagnosis in Scleroderma.
Job Titles:
- Chairman of Scientifc Advisory Board
- Chairman of Scientifc Advisory Board Novel Drug Discovery and Development
Jan joined IAG in 2018 to chair IAG's distinguished board of in-house scientists, imaging experts and academic collaborators and closely work with biotech and pharma partners. Jan's expertise and many years of experience are in the critical assessment of novel therapeutic agents and strategic positioning to maximize the chances of their success. Dr. Lundberg, a scientist with over 22 years of experience in global pharmaceutical R&D. Until recently he was heading R&D organization for Ely Lilly and previously - global research for AstraZeneca. He was involved with discovery of more than 200 candidate drugs and 22 approved products across multiple therapeutic areas, including immunology, oncology and neurology; he has been instrumental for the use of imaging cross therapeutic area projects including amyloid and tau PET imaging in Alzheimer's dementia. His career began in Karolinska institutet, where he was a professor of pharmacology and a co-founder of Aerocrine AB.
Dr. Carrino is an internationally renowned radiologist with particular expertise in diagnostic imaging and percutaneous image-guided intervention. He is a co-author on over 200 peer reviewed publications in a variety of areas. His interests are in musculoskeletal diagnostic imaging (MRI, CT, Ultrasound, Radiography), image guided therapy (IGT), medical informatics, standards and health services research. Currently, he serves as a Vice Chairman, Department of Radiology and Imaging at Hospital for Special Surgery. NY, USA.
Job Titles:
- Director, Strategic Alliances, Neuroscience
Neuroscientist with over two decades of experience in clinical and research neuroimaging, demonstrating a track record of academic and commercial leadership. Substantial expertise and domain knowledge in neurology and advanced neuroimaging analytics, connectomics, and clinical applications. Holding a Ph.D. in Neuroscience, Karol specializes in applying advanced imaging techniques to comprehend the intricate functions of the human brain. Actively engaged as a research scientist with an extensive academic record, particularly in discovering imaging biomarkers and biophenotypes of neurological disorders. Karol's ambition is to foster biotech partnerships aimed at leveraging neuroimaging data into precise and efficacious treatments for neurological conditions. Through collaborative efforts, he aspires to contribute to the development of groundbreaking solutions for improved patient outcomes.
Job Titles:
- Founder
- Member of the SENIOR LEADERSHIP Team
- President
- Founder and President Extensive Expertise in Identifying Innovative Approaches to Clinical Research, Disruptive Technology Platforms and Novel Therapeutics.
IAG's Scientific Expert in preclinical development and translational medicine. Dr. Stein began his career at Merck, Sharp and Dohme. He holds an MD and a PhD in Physiology & Pharmacology from Duke University. Over his 30 years of experience in the biopharmaceutical industry he played a pivotal role in bringing to the market Sustiva®, Fablyn®, Viviant®, PanRetin®, TargRetin®, Promacta® and Eliquis®. Dr. Stein is helping our bio-pharmaceutical partners to shape clinical development strategy, discovery and optimization technology platforms and portfolio in oncology and immune-oncology programs.
Job Titles:
- Chief Product Officer
- Chief Product Officer Leading Product Design and Engineering Organization With P & L Ownership and Customer Focus.
Leading Product Design and Engineering organization with P&L ownership and customer focus.
Job Titles:
- Chief Operating Officer
- Chief Operating Officer Building Teams and Scalling Capabilities to Deliver Global Scale Imaging Clinical Trials
World-class expert in biomarkers and distinguished scientist who is actively driving a global consortiums in brining imaging, omics and biomarker driven approaches for the development of novel treatments of auto-immune and musculoskeletal diseases. Ali Mobasheri is Professor, Project Leader and Senior Research Scientist at the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania. Previously he was Associate Dean (Research & Enterprise) and Head of the Department of Veterinary Preclinical Sciences at the University of Surrey. He was also Associate Professor and Reader in Comparative Physiology at the University of Nottingham and Lecturer/Senior Lecturer at the University of Liverpool. He served as a Visiting Adjunct Professor in the Distinguished Scientist Program of the Center of Excellence in Genomic Medicine Research, King AbdulAziz University, Jeddah, Kingdom of Saudi Arabia from 2013-2016. Ali successfully coordinated the EU FP7 funded D-BOARD consortium and is a member of the EU IMI funded APPROACH consortium. In addition to his work with IAG, currently Ali is supporting research for innovative medicine in Vilnius, Lithuania, co-leads osteoarthrisis dedicated APPROACH Consortium: http://www.approachproject.eu and consults for many pharmaceutical and biotech companies. He is also a President-Elect of the Osteoarthritis Research Society International (OARSI president from May 2019): https://www.oarsi.org/node/23 and a Scientific Advisory Board member for the SEN-OA targeting senescent cells in OA, Foreum (Foundation for Research in Rheumatology) Project http://www.foreum.org/sen_oa.cfm
Job Titles:
- Chief Executive Officer
- Chief Executive Officer of IAG Experienced Life Science Executive.
- COO at Invicro
Roughan Sheedy, previously COO at Invicro, brings over 20 years of success in leading and scaling high-performance imaging clinical research and technology companies. Roughan has held senior roles in Finance and Commercial and has a depth of experience of driving global growth and expansion throughout Europe, the US and Asia.